Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Sleep Med. 2018 Jun 2;51:153–166. doi: 10.1016/j.sleep.2018.05.018

Table 6.

Mood and Anxiety Outcomes

Baseline Post-Treatment 3-mo Follow-up Group × Timea,b
Measure Mean
(SD)
Mean
(SD)
Mean
(SD)
F p η2p
BDI-II (raw score)
 BBTi 9.77 (11.28) 8.90 (11.12) 8.42 (11.29) .74 .47 .013
 SMC 10.00 (6.51) 8.39 (6.45) 8.71 (6.52)
GDS (raw score)
 BBTi 3.29 (4.28) 3.03 (4.35) 2.71 (4.42) 2.25 .11 .039
 SMC 4.04 (7.95) 3.11 (3.17) 2.93 (3.11)
STAI-Y (raw score)
 BBTi 33.19 (12.84) 33.45 (12.79) 33.45 (12.95) 1.58 .21 .027
 SMC 38.96 (10.23) 37.18 (10.97) 39.32 (12.34)

Note. BBTi refers to Brief Behavioral Treatment of insomnia group (n = 32); SMC refers to Self-monitoring and Attention Controls (n = 30).

Abbreviations: BDI-II = Beck Depression Inventory-II; GDS = Geriatric Depression Scale; STAI-Y = State Trait Anxiety Inventory Form

a

Greenhouse-Geisser correction was applied to Group × Time interaction.

b

Guidelines for interpreting η2p: .01 = small, .06 = moderate, .14 = large (Cohen, 1977)